112 related articles for article (PubMed ID: 24246401)
1. First- versus second-generation endometrial ablation devices for treatment of menorrhagia: a systematic review, meta-analysis and appraisal of economic evaluations.
Kroft J; Liu G
J Obstet Gynaecol Can; 2013 Nov; 35(11):1010-1019. PubMed ID: 24246401
[TBL] [Abstract][Full Text] [Related]
2. Endometrial resection / ablation techniques for heavy menstrual bleeding.
Lethaby A; Hickey M; Garry R; Penninx J
Cochrane Database Syst Rev; 2009 Oct; (4):CD001501. PubMed ID: 19821278
[TBL] [Abstract][Full Text] [Related]
3. The effectiveness and cost-effectiveness of microwave and thermal balloon endometrial ablation for heavy menstrual bleeding: a systematic review and economic modelling.
Garside R; Stein K; Wyatt K; Round A; Price A
Health Technol Assess; 2004 Feb; 8(3):iii, 1-155. PubMed ID: 14754561
[TBL] [Abstract][Full Text] [Related]
4. Second generation endometrial ablation techniques for heavy menstrual bleeding: network meta-analysis.
Daniels JP; Middleton LJ; Champaneria R; Khan KS; Cooper K; Mol BW; Bhattacharya S;
BMJ; 2012 Apr; 344():e2564. PubMed ID: 22529302
[TBL] [Abstract][Full Text] [Related]
5. A cost-utility analysis of microwave and thermal balloon endometrial ablation techniques for the treatment of heavy menstrual bleeding.
Garside R; Stein K; Wyatt K; Round A; Pitt M
BJOG; 2004 Oct; 111(10):1103-14. PubMed ID: 15383113
[TBL] [Abstract][Full Text] [Related]
6. Microwave and thermal balloon ablation for heavy menstrual bleeding: a systematic review.
Garside R; Stein K; Wyatt K; Round A
BJOG; 2005 Jan; 112(1):12-23. PubMed ID: 15663392
[TBL] [Abstract][Full Text] [Related]
7. A double-blind randomized trial comparing the Cavaterm and the NovaSure endometrial ablation systems for the treatment of dysfunctional uterine bleeding.
Abbott J; Hawe J; Hunter D; Garry R
Fertil Steril; 2003 Jul; 80(1):203-8. PubMed ID: 12849825
[TBL] [Abstract][Full Text] [Related]
8. Novasure impedance control system versus microwave endometrial ablation for the treatment of dysfunctional uterine bleeding: a double-blind, randomized controlled trial.
Athanatos D; Pados G; Venetis CA; Stamatopoulos P; Rousso D; Tsolakidis D; Stamatopoulos CP; Tarlatzis BC
Clin Exp Obstet Gynecol; 2015; 42(3):347-51. PubMed ID: 26152008
[TBL] [Abstract][Full Text] [Related]
9. Meta-analysis of bipolar radiofrequency endometrial ablation versus thermal balloon endometrial ablation for the treatment of heavy menstrual bleeding.
Zhai Y; Zhang Z; Wang W; Zheng T; Zhang H
Int J Gynaecol Obstet; 2018 Jan; 140(1):3-10. PubMed ID: 28984905
[TBL] [Abstract][Full Text] [Related]
10. Levonorgestrel-Releasing Intrauterine System (52 mg) for Idiopathic Heavy Menstrual Bleeding: A Health Technology Assessment.
Health Quality Ontario
Ont Health Technol Assess Ser; 2016; 16(18):1-119. PubMed ID: 27990196
[TBL] [Abstract][Full Text] [Related]
11. Office endometrial ablation with local anesthesia using the HydroThermAblator system: Comparison of outcomes in patients with submucous myomas with those with normal cavities in 246 cases performed over 5(1/2) years.
Glasser MH; Heinlein PK; Hung YY
J Minim Invasive Gynecol; 2009; 16(6):700-7. PubMed ID: 19896596
[TBL] [Abstract][Full Text] [Related]
12. NovaSure bipolar radiofrequency endometrial ablation: report of 200 cases.
Baskett TF; Clough H; Scott TA
J Obstet Gynaecol Can; 2005 May; 27(5):473-6. PubMed ID: 16100642
[TBL] [Abstract][Full Text] [Related]
13. First and second-generation endometrial ablation devices: A network meta-analysis.
Marchand GJ; Masoud A; Grover S; King A; Brazil G; Ulibarri H; Parise J; Arroyo A; Coriell C; Moir C; Govindan M
BMJ Open; 2024 May; 14(5):e065966. PubMed ID: 38806429
[TBL] [Abstract][Full Text] [Related]
14. Economic evaluation of hysteroscopic endometrial ablation versus vaginal hysterectomy for menorrhagia.
Vilos GA; Pispidikis JT; Botz CK
Obstet Gynecol; 1996 Aug; 88(2):241-5. PubMed ID: 8692509
[TBL] [Abstract][Full Text] [Related]
15. A randomized, multicenter trial of safety and efficacy of the NovaSure system in the treatment of menorrhagia.
Cooper J; Gimpelson R; Laberge P; Galen D; Garza-Leal JG; Scott J; Leyland N; Martyn P; Liu J
J Am Assoc Gynecol Laparosc; 2002 Nov; 9(4):418-28. PubMed ID: 12386350
[TBL] [Abstract][Full Text] [Related]
16. NovaSure impedance-controlled system for endometrial ablation.
Gallinat A; Nugent W
J Am Assoc Gynecol Laparosc; 2002 Aug; 9(3):283-9. PubMed ID: 12101323
[TBL] [Abstract][Full Text] [Related]
17. Endometrial ablation.
Munro MG
Best Pract Res Clin Obstet Gynaecol; 2018 Jan; 46():120-139. PubMed ID: 29128205
[TBL] [Abstract][Full Text] [Related]
18. NovaSure impedance controlled system for endometrial ablation: three-year follow-up on 107 patients.
Gallinat A
Am J Obstet Gynecol; 2004 Nov; 191(5):1585-9. PubMed ID: 15547528
[TBL] [Abstract][Full Text] [Related]
19. Endometrial ablation: first- vs. second-generation techniques.
Angioni S; Pontis A; Nappi L; Sedda F; Sorrentino F; Litta P; Haimovich S; Melis GB
Minerva Ginecol; 2016 Apr; 68(2):143-53. PubMed ID: 26928420
[TBL] [Abstract][Full Text] [Related]
20. Second-generation endometrial ablation treatment: Novasure.
Bongers MY
Best Pract Res Clin Obstet Gynaecol; 2007 Dec; 21(6):989-94. PubMed ID: 17490913
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
